• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恰加斯心肌病——百年之后,我们处于何种境地?

Chagas cardiomyopathy--where do we stand after a hundred years?

机构信息

Division of Cardiology, Hospital de Clínicas de Porto Alegre and Faculty of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

出版信息

Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):300-16. doi: 10.1016/j.pcad.2009.11.008.

DOI:10.1016/j.pcad.2009.11.008
PMID:20109600
Abstract

A hundred years from its description, Chagas cardiomyopathy remains a challenging disease. Although successful vector-control strategies have decreased the incidence of Chagas disease in several Latin American countries, both migration to urban areas and immigration have spread the disease worldwide; and now, blood transfusion, organ transplantation, and vertical transmission are a concern. The pathogenesis of Chagas cardiomyopathy involves complex host-parasite interactions, where low-grade but incessant systemic infection and triggered autoimmune reaction are the main mechanisms for its development, with the contribution of autonomic damage and microvascular disturbances. Chagas cardiomyopathy is the most important clinical presentation of Chagas disease and comprises a wide range of manifestations, including heart failure, arrhythmias, heart blocks, sudden death, thromboembolism, and stroke. Recently, simple clinical prognostic scores have been developed to identify high-risk patients and help with management. The treatment of Chagas cardiomyopathy focuses mostly on managing heart failure, arrhythmias, and thromboembolism. The role of specific antiparasitic therapy in the chronic form is not yet defined, and a randomized trial is now under way to address this crucial point. In this article, we review the main clinical aspects of Chagas cardiomyopathy and underscore some upcoming challenges for the appropriate control, diagnosis, and management of this complex disease.

摘要

从描述到现在已经过去了一百年,Chagas 心肌病仍然是一种具有挑战性的疾病。尽管成功的病媒控制策略已经降低了几个拉丁美洲国家的 Chagas 病发病率,但移民到城市地区和移民已经使该病在全球范围内传播;现在,输血、器官移植和垂直传播令人担忧。Chagas 心肌病的发病机制涉及复杂的宿主-寄生虫相互作用,其中低度但持续不断的全身感染和触发的自身免疫反应是其发展的主要机制,自主损伤和微血管紊乱也有贡献。Chagas 心肌病是 Chagas 病最重要的临床表现,包括心力衰竭、心律失常、心脏传导阻滞、猝死、血栓栓塞和中风。最近,已经开发出简单的临床预后评分来识别高危患者并帮助管理。Chagas 心肌病的治疗主要集中在管理心力衰竭、心律失常和血栓栓塞。在慢性形式中,特定的抗寄生虫治疗的作用尚未确定,目前正在进行一项随机试验来解决这一关键问题。本文综述了 Chagas 心肌病的主要临床方面,并强调了适当控制、诊断和管理这种复杂疾病所面临的一些新挑战。

相似文献

1
Chagas cardiomyopathy--where do we stand after a hundred years?恰加斯心肌病——百年之后,我们处于何种境地?
Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):300-16. doi: 10.1016/j.pcad.2009.11.008.
2
Diagnosis and Management of Chagas Cardiomyopathy in the United States.美国的恰加斯心肌病的诊断与管理。
Curr Cardiol Rep. 2018 Oct 11;20(12):131. doi: 10.1007/s11886-018-1077-5.
3
An update on the management of Chagas cardiomyopathy.恰加斯心肌病管理的最新进展。
Expert Rev Anti Infect Ther. 2007 Aug;5(4):727-43. doi: 10.1586/14787210.5.4.727.
4
Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association.恰加斯心肌病:当前临床知识和管理的更新:美国心脏协会的科学声明。
Circulation. 2018 Sep 18;138(12):e169-e209. doi: 10.1161/CIR.0000000000000599.
5
Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation.在晚期慢性恰加斯心脏病和心脏移植后再激活的病例中,对克氏锥虫离散型单位进行分子鉴定。
Clin Infect Dis. 2010 Sep 1;51(5):485-95. doi: 10.1086/655680.
6
[Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic].[在克氏锥虫感染非地方性流行地区慢性查加斯心脏病的诊断、管理与治疗]
Rev Esp Cardiol. 2007 Mar;60(3):285-93.
7
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).一项评估病因治疗对恰加斯心肌病影响的随机安慰剂对照试验的原理与设计:苯硝唑中断锥虫病评估试验(BENEFIT)
Am Heart J. 2008 Jul;156(1):37-43. doi: 10.1016/j.ahj.2008.04.001.
8
Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report.原位肝移植后供体和受体血清学检测克氏锥虫均为阴性的急性恰加斯心肌病:一例报告
Transplant Proc. 2008 Apr;40(3):875-8. doi: 10.1016/j.transproceed.2008.02.032.
9
Diagnosis and management of Chagas disease and cardiomyopathy.**诊断和治疗**:恰加斯病和心肌病。
Nat Rev Cardiol. 2012 Oct;9(10):576-89. doi: 10.1038/nrcardio.2012.109. Epub 2012 Jul 31.
10
The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease.恰加斯心脏病的流行病学、临床表现及治疗
Clin Cardiol. 2015 Sep;38(9):565-9. doi: 10.1002/clc.22421. Epub 2015 May 21.

引用本文的文献

1
Single-base polymorphism of the ACE2 and TNF-alpha genes in patients with the cardiac and indeterminate forms of Chagas disease.恰加斯病心脏型和不确定型患者中ACE2和TNF-α基因的单碱基多态性
Braz J Infect Dis. 2025 Sep-Oct;29(5):104574. doi: 10.1016/j.bjid.2025.104574. Epub 2025 Aug 14.
2
Diagnosis and management of chagasic cardiomyopathy patients in several institutions in Argentina.阿根廷多家机构中恰加斯病性心肌病患者的诊断与管理
Front Parasitol. 2023 Jul 24;2:1195646. doi: 10.3389/fpara.2023.1195646. eCollection 2023.
3
Inorganic Polyphosphate Is in the Surface of but Is Not Significantly Secreted.
无机多聚磷酸盐存在于表面但分泌量不显著。
Pathogens. 2024 Sep 9;13(9):776. doi: 10.3390/pathogens13090776.
4
Unraveling the Missing Pieces: Exploring the Gaps in Understanding Chagas Cardiomyopathy.解开缺失的环节:探索恰加斯心肌病认识上的差距。
Cureus. 2024 Aug 15;16(8):e66955. doi: 10.7759/cureus.66955. eCollection 2024 Aug.
5
Circulating microRNAs as biomarkers of Chagas cardiomyopathy.循环微RNA作为恰加斯心肌病的生物标志物
Front Cardiovasc Med. 2023 Dec 19;10:1250029. doi: 10.3389/fcvm.2023.1250029. eCollection 2023.
6
Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research.探讨心电图在恰加斯病研究中的历史背景和临床意义。
Rev Soc Bras Med Trop. 2023 Dec 15;56:0506. doi: 10.1590/0037-8682-0506-2023. eCollection 2023.
7
A Case of Chagas Cardiomyopathy in Western Virginia: Worlds Away?弗吉尼亚州西部的一例恰加斯心肌病病例:相隔甚远?
Cureus. 2023 Jul 19;15(7):e42158. doi: 10.7759/cureus.42158. eCollection 2023 Jul.
8
SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023.巴西心脏病学会2023年恰加斯病心肌病患者诊断与治疗指南
Arq Bras Cardiol. 2023 Jun 26;120(6):e20230269. doi: 10.36660/abc.20230269.
9
Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease.二维应变衍生参数可为恰加斯病患者发展为恰加斯心肌病及死亡提供独立的预测指标。
Int J Cardiol Heart Vasc. 2022 Jan 10;38:100955. doi: 10.1016/j.ijcha.2022.100955. eCollection 2022 Feb.
10
Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care.恰加斯心脏病:诊断、表现、治疗及护理概述
World J Cardiol. 2021 Dec 26;13(12):654-675. doi: 10.4330/wjc.v13.i12.654.